23 results
management diagnosis medications comparison idsa pharmacotherapy algorithm dermatology hivaids infections opportunistic prevention chemotherapy differential doac interactions lupus mycobacterium rheumatology systemic
Topical drug formulations, comparison and considerations #pharmacology #table #medications #comparison #drugs #treatment #pharmacotherapy #dermatology
Topical drug formulations ... considerations #pharmacology ... #table #medications ... #treatment #pharmacotherapy ... #dermatology
Managing warfarin INR Warfarin dosage must be individualized according to the patient's response to the drug, and
response to the drug ... #treatment #medications ... #table #pharmacotherapy ... #hematology #warfarin ... #dosing
PDE5 inhibitors are usually the drugs of first choice for erectile dysfunction. PDE5 inhibitors enhance an erection that is
are usually the drugs ... #pharmacology #comparison ... #treatment #medications ... #dosing #drugs ... #table #pharmacotherapy
Anti-infective stewardship, including tips for using anti-infectives wisely, criteria for stepdown from IV to PO dosage
including tips for using ... #pharmacology #antibiotics ... #medications #table ... #treatment #drugs
Drugs Used for the Treatment of COVID-19 Infection ** Editor Note (from ophthalmology MD input) - Hydroxychloroquine/chloroquine
Drugs Used for the ... Even with macular disease ... smfarmhosp_smfh #Drugs ... #COVID19 #Pharmacology ... #Table #Management
Treatment algorithm for VTE in Malignancy (A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... §Assess drug-drug ... bleeding risk during ... Anticoagulation #Management #Hematology ... #Oncology
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB) •
Individualized Treatment ... children with TB disease ... MDRTB #management #Treatment ... antimicrobials #regimens #pharmacology ... #dosing #idsa #
(DOAC interactions) Cancer-treatment specific inducers (↑) and inhibitors (↓) of cytochrome p450 CYP3A4 and P-glycoprotein. DOACs are substrates
interactions) Cancer-treatment ... #Chemotherapy #Oncology ... #Hematology #Interactions ... #Table #Pharmacology
Systemic Therapy for Hepatocellular Carcinoma - AGA Clinical Practice Guideline First Line Treatment for HCC with Preserved
First Line Treatment ... for Disease Progression ... #Management #Hepatology ... Gastroenterology #oncology ... #Pharmacology
Summary of actions of some Cholinergic Agonists Bethanechol • Used in treatment of urinary retention • Binds
Produces miosis during ... for Alzheimer's disease ... moderate to severe disease ... Cholinergic #Agonists #Pharmacology ... #Table #Summary
No results found for "disease table hematology pharmacology dosing cardiology treatment drugs oncology"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #disease #table #hematology #pharmacology #dosing #cardiology #treatment #drugs #oncology